Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreTrump vs Harris: Who Is Better for The Stock Market?
With an election close at hand, Americans will soon be asked to make a choice between two starkly different candidates and political parties. Though the outcome of the election will affect everything from America’s foreign policy to questions over the balance between state and federal power, the economy is a prominent highlight for both parties and many voters.
» Read more about: Trump vs Harris: Who Is Better for The Stock Market? »
Read MoreIs Etsy An All-Time Buy Now?
Why is Etsy stock so low? ETSY is down 36.7% year-to-date following disappointing sales reports that missed Street estimates.
The stock that nearly reached $300 per share in 2021 but is now trading under $50 per share. Adding insult to injury, Etsy (NASDAQ: ETSY) was recently dropped from the S&P 500 index.
» Read more about: Is Etsy An All-Time Buy Now? »
Read MoreWhat Price Exactly Should Palantir Trade At?
Palantir Technologies (NYSE:PLTR) has successfully ridden the AI wave of the last two years to produce outstanding shareholder returns.
The stock traded at less than $7 as recently as the beginning of 2023 but has since risen by over 6x. This sudden spike in prices begs the question of whether the market is valuing Palantir appropriately today.
» Read more about: What Price Exactly Should Palantir Trade At? »
Read More1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
Billionaire Bets on Fast Growth Unit In Boring Stock
If you only look at consumer trends within the United States, it might seem odd that Philip Morris’s stock has done so well. Aren’t people giving up cigarettes?
For the most part, they are, but the company has planned for the effects of smoking cessation programs. The share price speaks to Philip Morris’s success.
» Read more about: Billionaire Bets on Fast Growth Unit In Boring Stock »
Read MoreThe Spotlight
Why Is Buffett Pouring Into This High Yield Bet
2024 has been a surprising year for Warren Buffett and Berkshire Hathaway. The company became the first American business outside of the tech sector to achieve a $1 trillion valuation, and an unusually buoyant stock market has caused many of its holdings to gain substantially in value.
Despite these successes, Buffett personally appears to be turning bearish.
» Read more about: Why Is Buffett Pouring Into This High Yield Bet »
Read MoreThe Daily
6 Great Commodity ETFs For 2025
Commodity ETFs can provide an important layer of diversification for your portfolio.
getty
Ready to move your portfolio beyond stocks and bonds? A commodity ETF may be your next investing move. Commodity exposure adds a layer of diversification to your portfolio,